OpenIPO®:
|
Avalon Pharmaceuticals, Inc.
|
|
The OpenIPO auction for Avalon Pharmaceuticals, Inc. has been completed.
Avalon has
set an offering price of $10.50. All auction participants with bids at or above the offering price will receive a pro-rated percentage of the shares bid for, rounded to the nearest 100 shares. --> |
|
 |
Successful bidders should be able to see the executed trade in their brokerage accounts on Thursday, September 29, 2005. To view
the completed trade, login to your WRH+Co brokerage account.
|
|
Avalon Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery and development of small molecule therapeutics for the treatment of cancer. |
|
View prospectus (dated 09/29/05)
| Offering Type |
OpenIPO |
| Exchange |
NASDAQ and/or Pacific Exchange |
| Symbol |
avrx |
| Lead Manager |
WR Hambrecht + Co |
| Co-Manager(s) |
Legg Mason Wood Walker, Inc.
Susquehanna Financial Group, LLLP |
|
|
| Share Type |
|
| Total Shares Offered |
2,750,000 |
| Issuer |
2,750,000 |
| Shareholders |
0 |
| Price |
$10.50 |
| Offering Date |
09/28/05 |
|
|
Auction Timeline
|
|
